Acad9 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ACAD9 Protein | |
|---|---|
| Protein Name | Acyl-CoA dehydrogenase family member 9 |
| Gene | ACAD9 |
| UniProt ID | Q9H845 |
| PDB ID | 3NW7, 5K7P |
| Molecular Weight | ~68 kDa |
| Subcellular Localization | Mitochondrial matrix |
| Protein Family | Acyl-CoA dehydrogenase family |
Acyl-CoA dehydrogenase family member 9 (ACAD9) is a mitochondrial flavoprotein that plays essential roles in fatty acid oxidation and oxidative phosphorylation. Unlike other members of the ACAD family that function in β-oxidation of specific-chain-length fatty acids, ACAD9 has a unique function in facilitating the assembly of mitochondrial complex I (NADH:ubiquinone oxidoreductase), the largest respiratory chain complex [1]. Mutations in ACAD9 cause a complex I deficiency disorder characterized by cardiomyopathy, encephalopathy, and often early-onset death, highlighting its critical importance in human health [2].
ACAD9 is a homodimeric flavoprotein with characteristic ACAD domain architecture:
| Feature | Description |
|---|---|
| Monomer size | 621 amino acids |
| Quaternary structure | Homodimer (functional unit) |
| Flavin adenine dinucleotide (FAD) | Prosthetic group required for catalytic activity |
| Substrate-binding pocket | Specific for unsaturated C14-C16 acyl-CoAs |
Crystal structures have revealed the molecular basis for ACAD9 substrate specificity and its unique N-terminal extension that mediates complex I assembly [3].
ACAD9 catalyzes the first step in the β-oxidation of fatty acids:
The most critical function of ACAD9 is its role in mitochondrial complex I assembly:
ACAD9 deficiency impairs complex I activity, disrupting the primary entry point for electrons into the respiratory chain.
Mutations in ACAD9 cause a severe mitochondrial disorder:
Clinical Features:
Genetics:
Treatment:
Neurons rely heavily on oxidative phosphorylation:
| Process | Relevance to ACAD9 |
|---|---|
| Glucose metabolism | Primary neuronal fuel |
| Fatty acid oxidation | Secondary energy source during stress |
| Complex I function | Critical for ATP production |
| Calcium handling | Mitochondria buffer calcium loads |
ACAD9 deficiency leads to impaired ATP production, making neurons particularly vulnerable due to their high energy demands.
| Partner | Interaction Type | Functional Outcome |
|---|---|---|
| NDUFAF1 | Direct binding | Complex I assembly scaffold |
| ETFDH | Metabolic | Electron transfer to ETF |
| FAD | Prosthetic group | Catalytic cofactor |
| ND1 | Assembly | Core complex I subunit |
| ND2 | Assembly | Core complex I subunit |
The study of Acad9 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.